SCHEMBL13664872

SCHEMBL13664872

CC(C)(C)OC(=O)NC(C(=O)Nc1ccc(Cl)c(Cl)c1)C(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.45
EPHX1 P07099 1/20 0.45
EPHX2 P34913 1/20 0.45
ALDH1A1 P00352 1/20 0.45
THRB P10828 1/20 0.45
POLB P06746 1/20 0.44
CYP3A4 P08684 1/20 0.43
APEX1 P27695 1/20 0.43
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA5A P35218 1/20 0.42
CA9 Q16790 1/20 0.42
MAPK14 Q16539 2/20 0.42
S1PR3 Q99500 1/20 0.42
EGFR P00533 1/20 0.42
RAF1 P04049 3/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28438966 0.87 PDK1 (0.58) CA2CA9MEN1MAPTRAB9A
SCHEMBL28302624 0.87 PDK1 (0.58) CA2CA9MEN1MAPTRAB9A
SCHEMBL30340914 0.86 ALDH1A1 (0.58) SMN1; SMN2EPHX1EPHX2ALDH1A1THRB
SCHEMBL26503173 0.86 ALDH1A1 (0.58) SMN1; SMN2EPHX1EPHX2ALDH1A1THRB
SCHEMBL13664903 0.86 ALDH1A1 (0.58) SMN1; SMN2EPHX1EPHX2ALDH1A1THRB
SCHEMBL16303890 0.82 EPHX1 (0.58) EPHX1EPHX2ALDH1A1POLBCYP3A4
SCHEMBL13664813 0.81 SMN1; SMN2 (0.69) SMN1; SMN2POLBCA2CA4CA9
SCHEMBL30135221 0.80 MEN1 (0.50) SMN1; SMN2ALDH1A1POLBS1PR3MEN1
SCHEMBL13664730 0.79 HDAC4 (0.54) SMN1; SMN2POLBCA2CA4CA9
SCHEMBL30135201 0.78 CTSS (0.42) ALDH1A1CA2CA4CA9EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009119528-A1 HETEROCYCLIC COMPOUND 武田薬品工業株式会社 (JP) 2009-10-01 WO disclosed